The Lancet: March 07, 2008
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
In this week's podcast, Martin Bachmann discusses results of a phase II study showing how a vaccine to inhibit angiotensin II is safe and well tolerated; the vaccine also shows promising results in reducing blood pressure for people with hypertension. Authors of a Comment state: "Vaccination for hypertension may turn out to be very useful in many patients." Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://fa...
